GSK planning job cuts at Quebec vaccines plant
October 18, 2011Manufacturing and Production Canada, GSK, Quebec, vaccines
GlaxoSmithKline has decided to cut around 9% of its workforce in Quebec City, Canada, with a vaccines manufacturing plant bearing …
Angel Bio plans joint venture with Russian drugmaker
October 18, 2011Manufacturing and Production Angel Biotechnology, Materia Medica, Russia, biologics
UK contract manufacturing organisation Angel Biotechnology has agreed to set up a joint venture with Russian counterpart Materia Medica Holding …
NICE recommends Lilly’s long-acting Bydureon
October 18, 2011Sales and Marketing Bydureon, NICE, diabetes
NICE has recommended Eli Lilly’s long-acting diabetes drug Bydureon after the failure of oral treatments. Bydureon (exenatide) – a long-acting …
Grant nominated for key NHS Commissioning Board post
October 18, 2011Commissioning Board, Malcolm Grant, NHS, Nicholson
The government has named its choice for one of the key roles at the new NHS Commissioning Board. Professor Malcolm …
EMA resources stretched by Mediator scandal
October 18, 2011Research and Development, Sales and Marketing EMA, Mediator
The European Medicines Agency has been forced to use ‘considerable resources’ to deal with a flood of enquiries over Mediator …
Pharma Brands – join the live discussion on Twitter
October 17, 2011Sales and Marketing branding, brands
Do pharma marketers need to kill off the ‘smiley happy people’ and update their approach to branding? InPharm will host …
Roche buys US firm Anadys for $230 million
October 17, 2011Research and Development, Sales and Marketing Roche, hepatitis C
Roche has acquired US firm Anadys for $230 million, bolstering its infectious drugs pipeline. California-based Anadys develops oral, small molecule …
Russian diabetes market to grow to $1.7 billion
October 17, 2011Sales and Marketing Russia, diabetes
Russia’s diabetes market is set be worth $1.7 billion by 2015, according to a new report. Industry analysts Decision Resources’ …
Frontera appoints creative director
October 14, 2011Medical Communications appointment, medical communications
Covent Garden-based comms agency Frontera has appointed Bruno Cepollina as creative director. The former creative partner at McCann Healthcare is …
Health service’s £1bn patent expiry windfall
October 14, 2011Sales and Marketing generics, patent expiry
Patent expiries could shave £1 billion from the NHS drugs bill, and could yield major savings by 2015 for the …
Pfizer to research prescription drug costs for the elderly
October 14, 2011Sales and Marketing Pfizer
Pfizer has signed a five-year research pact with US healthcare insurer Humana to investigate treatment costs for the elderly. The …
Genzyme completes expansion at Waterford plant
October 14, 2011Manufacturing and Production Genzyme, Sanofi
Sanofi’s Genzyme unit has officially opened a €150 million expansion at its ten-year-old biotechnology facility in Waterford, Ireland that will …
NICE: Bristol-Myers Squibb’s Yervoy too costly
October 14, 2011Sales and Marketing NICE, Yervoy
Bristol Myers Squibb has failed to win NICE backing for its melanoma drug Yervoy after the Institute judged its £80,000 …
NHS regions back Avastin for eye disease
October 14, 2011Sales and Marketing avastin
Regional NHS authorities around England are approving the use of Avastin instead of Lucentis for ophthalmology patients. A number of …
Keep taking the tablets
October 13, 2011Sales and Marketing ipad, tablet pc
Online giant Amazon has just launched Fire, its rival to Apple’s trendsetting iPad, upping the ante in the ‘tablet’ market. …
Roche revenue drops as key products underperform
October 13, 2011Sales and Marketing Roche
Roche has posted worse-than-expected figures for the first nine months of this year after key products failed to shine and …
NICE recommends RoActemra for early use in arthritis
October 13, 2011Sales and Marketing NICE, RoActemra
NICE has recommended Roche’s drug RoActemra be used at an earlier stage for some arthritis patients. In draft guidance NICE …
Lords’ Health Bill challenge fails
October 12, 2011NHS reform
The government’s NHS reforms have survived a challenge in the House of Lords that have delayed them until the next …
Bayer planning joint venture to make drugs in Russia
October 12, 2011Manufacturing and Production Bayer, pharma manufacturing news
Germany’s Bayer AG has joined a number of its peers in the pharmaceutical industry with the signing of an agreement …
Pharmacovigilance at heart of EC patient information proposals
October 12, 2011Medical Communications, Sales and Marketing patient information
Pharmacovigilance is at the centre of revised proposals announced this week setting out what information pharma firms can put on …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
